Cargando…

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

Hypoxia is an environmental stressor that is instigated by low oxygen availability. It fuels the progression of solid tumors by driving tumor plasticity, heterogeneity, stemness and genomic instability. Hypoxia metabolically reprograms the tumor microenvironment (TME), adding insult to injury to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abou Khouzam, Raefa, Zaarour, Rania Faouzi, Brodaczewska, Klaudia, Azakir, Bilal, Venkatesh, Goutham Hassan, Thiery, Jerome, Terry, Stéphane, Chouaib, Salem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861358/ https://www.ncbi.nlm.nih.gov/pubmed/35211123 http://dx.doi.org/10.3389/fimmu.2022.828875

Ejemplares similares

Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?
por: Hassan Venkatesh, Goutham, et al.
Publicado: (2021)

Genomic Analysis of Waterpipe Smoke-Induced Lung Tumor Autophagy and Plasticity
por: Zaarour, Rania Faouzi, et al.
Publicado: (2022)

Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
por: Abou Khouzam, Raefa, et al.
Publicado: (2021)

Role of Hypoxia-Mediated Autophagy in Tumor Cell Death and Survival
por: Zaarour, Rania F., et al.
Publicado: (2021)

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
por: Abou Khouzam, Raefa, et al.
Publicado: (2021)

Waterpipe smoke condensate influences epithelial to mesenchymal transition and interferes with the cytotoxic immune response in non-small cell lung cancer cell lines
por: Zaarour, Rania Faouzi, et al.
Publicado: (2021)

Hypoxia increases mutational load of breast cancer cells through frameshift mutations
por: Hassan Venkatesh, Goutham, et al.
Publicado: (2020)

Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells
por: Abou Khouzam, Raefa, et al.
Publicado: (2023)

Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity
por: Terry, Stéphane, et al.
Publicado: (2018)

Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
por: Abou Khouzam, Raefa, et al.
Publicado: (2023)

Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition
por: Engelsen, Agnete S. T., et al.
Publicado: (2022)

Hypoxia and Sleep-disordered Breathing: Friend or Foe?
por: Eckert, Danny J., et al.
Publicado: (2022)

Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
por: Li, Weiying, et al.
Publicado: (2018)

Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity
por: Ziani, Linda, et al.
Publicado: (2021)

Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
por: Ziani, Linda, et al.
Publicado: (2018)

Renal hypoxia–HIF–PHD–EPO signaling in transition metal nephrotoxicity: friend or foe?
por: Thévenod, Frank, et al.
Publicado: (2022)

Tumour angiogenesis normalized by myo‐inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response
por: El Hafny‐Rahbi, Bouchra, et al.
Publicado: (2021)

Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
por: Majewska, Aleksandra, et al.
Publicado: (2021)

T-cell repertoire diversity: friend or foe for protective antitumor response?
por: Porciello, Nicla, et al.
Publicado: (2022)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
por: Janji, Bassam, et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

“Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy
por: Janji, Bassam, et al.
Publicado: (2021)

The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment
por: Chouaib, Salem, et al.
Publicado: (2018)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Media and breastfeeding: Friend or foe?
por: Brown, Jane D, et al.
Publicado: (2008)

Friend to the brain, foe to the spine
por: Maxmen, Amy
Publicado: (2008)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Medicine And Money: Friends Or Foe?
por: Muula, Adamson S.
Publicado: (2006)

Bacterial toxins: friends or foes?
por: Schmitt, C K, et al.
Publicado: (1999)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Cricoid pressure – friend or foe?
por: Harris, Tim, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_12t6eqp7hl2ut4vbg23mjh6qbc